Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Apex Healthcare Bhd (XKLS:7090) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Apex Healthcare Bhd Forward PE Ratio Related Terms
Apex Healthcare Bhd Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Apex Healthcare Bhd's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apex Healthcare Bhd Forward PE Ratio Chart
Apex Healthcare Bhd Annual Data
Trend
Forward PE Ratio
Apex Healthcare Bhd Quarterly Data
Forward PE Ratio
XKLS:7090 vs MCK, COR, CAH: Forward PE Ratio Comparison
For the Medical Distribution subindustry, Apex Healthcare Bhd's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apex Healthcare Bhd Forward PE Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Apex Healthcare Bhd's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Apex Healthcare Bhd (XKLS:7090) has a Forward PE Ratio of 21.75 as of Jul. 30, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Apex Healthcare Bhd and its competitors.
Is Apex Healthcare Bhd's Forward PE Ratio too high?
Apex Healthcare Bhd's current Forward PE Ratio is 21.75. The Medical Distribution industry median Forward PE Ratio is 15.06. Apex Healthcare Bhd's value of 21.75 is 44.4% above this industry median. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's Forward PE Ratio compare to MCK and COR?
Apex Healthcare Bhd's Forward PE Ratio of 21.75 can be compared against companies in the Medical Distribution industry. The industry median Forward PE Ratio is 15.06. Apex Healthcare Bhd's value of 21.75 is 44.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Distribution company?
The median Forward PE Ratio among Medical Distribution companies is 15.06, based on 51 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apex Healthcare Bhd's current Forward PE Ratio of 21.75 is 44.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Apex Healthcare Bhd and its competitors. For the Medical Distribution industry, the median Forward PE Ratio is 15.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apex Healthcare Bhd's current Forward PE Ratio is 21.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current Forward PE Ratio of 21.75. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current Forward PE Ratio is 21.75 and 44.4% above the Medical Distribution industry median of 15.06. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current Forward PE Ratio is 21.75 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?
Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued.
The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.
Key valuation signals for XKLS:7090:
Forward PE Ratio: 21.75
GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
Industry Position: 44.4% above the Medical Distribution median
No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score
Get the complete analysis for XKLS:7090
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7090 has been successfully added to your 
